PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

No link between HIV-prevention pill Truvada and increased sexual risk behavior

Biological markers confirm behavioral data; underscore drug's effectiveness

2013-12-19
(Press-News.org) Contact information: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes
No link between HIV-prevention pill Truvada and increased sexual risk behavior Biological markers confirm behavioral data; underscore drug's effectiveness

SAN FRANCISCO, CA—December 18, 2013—In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention. Led by Gladstone Institutes' Investigator Robert Grant, MD, MPH, this research was hailed as an important step towards reducing the worldwide HIV/AIDS epidemic. Now, a new study provides further proof that regular Truvada use can reduce one's risk for contracting HIV—without increasing sexual risk behavior.

This research, published today in the online journal PLOS ONE, builds on the 2010 Global iPrEx clinical study, which reported that Truvada, an FDA-approved drug used for years to treat HIV-positive patients, could also prevent new infections in people likely to come in contact with the virus. Lending further support to Truvada's efficacy, a 2012 follow-up study found that taking Truvada regularly reduced risk of HIV infection by more than 90%.

Questions about the drug's real-world effectiveness remained, however, particularly concerning the issue of whether taking the drug could lead to a behavioral effect called risk compensation. Risk compensation is the notion that individuals adjust their behavior in response to a change in their perceived level of risk—such as increasing exposure to the sun in response to sunscreen use. While iPrEx participants did self-report decreases in sexual risk behavior over the course of the study, Dr. Grant and his team decided to examine those findings more closely, by studying biological markers of risk behavior.

"After the initial iPrEx study, there was concern that self-reported behavior may not tell the whole story," said Dr. Grant, who is also a professor at the University of California, San Francisco (UCSF), with which Gladstone is affiliated. "Here, we not only gathered behavioral data, but we also tested each participant for both HIV and syphilis—allowing us to map over time how reported changes in overall behavior correlated with actual changes in infection rates."

The multi-year iPrEx study enrolled nearly 2500 men and transgender women in Peru, Ecuador, South Africa, Brazil, Thailand and the United States at risk for HIV infection. Half of the participants were given Truvada, while the other half were given a placebo. Unaware as to whether they were being given Truvada or the placebo, participants were also asked whether they believed they were receiving Truvada—and whether they thought it was working.

"If risk compensation were occurring, those who believed they were receiving Truvada and that it was effective would be more likely to increase their sexual risk behavior," explained Julia Marcus, PhD, MPH, the paper's first author. "However, our results revealed the opposite: rates of both HIV and syphilis infections went down, and there was no increase in sexual risk behavior."

"Our results suggest that HIV prevention strategies such as Truvada don't result in risk compensation because they provide an opportunity for participants to actively engage in and reduce their risk of HIV infection," added Dr. Grant. "Engagement, which also includes counseling, provision of condoms and management of other sexually transmitted infections leads to motivation, which comes at a time when motivation for preventing new HIV infections is vital to curbing the spread of this worldwide epidemic."

"The research team's findings should help to minimize reluctance to embrace Truvada over fears that it could actually lead to increased risk and more infections," said Jeffrey Crowley, distinguished scholar at the O'Neill Institute for National and Global Health Law at Georgetown University and former director of the White House Office of National AIDS Policy. "This study reinforces the importance of drugs like Truvada as one component of a comprehensive plan for supporting people living with HIV and—importantly—preventing others from becoming infected."



INFORMATION:

Dr. Marcus, who performed this research while a graduate student at the University of California, Berkeley, is now a postdoctoral fellow at the Kaiser Permanente Division of Research. Other research participants include Gladstone Senior Research Associate Vanessa MacMahan, as well as UCSF Professors David Glidden, PhD, Albert Liu MD, MPH, and Susan Buchbinder, MD. The research was funded by the US National Institutes of Health, with co-funding from the Bill and Melinda Gates Foundation.

About Truvada

Truvada is manufactured by Gilead Sciences, which donated the drug for the studies but was not otherwise involved in the research. Truvada is one tablet that contains two medications (emtricitabine and tenofovir disoproxil fumarate). The medications are available in generic forms at cost in the poorest countries of the world.

About the Gladstone Institutes

Gladstone is an independent and nonprofit biomedical-research organization dedicated to accelerating the pace of scientific discovery and innovation to prevent, treat and cure cardiovascular, viral and neurological diseases. Gladstone is affiliated with the University of California, San Francisco.



ELSE PRESS RELEASES FROM THIS DATE:

Deep brain stimulation may help with driving for people with Parkinson's disease

2013-12-19
Deep brain stimulation may help with driving for people with Parkinson's disease MINNEAPOLIS – Deep brain stimulation may have a beneficial effect on driving ability for people with Parkinson's disease, according to a new study published in the December 18, 2013, ...

Coping with stress in a changing world

2013-12-19
Coping with stress in a changing world If there is something that we all know about in the 21st century it is stress, whether it's the stress of work, financial stress or the stress of getting the next grant funded; we are all familiar with that heart-pounding, ...

Stress reaction gene linked to death, heart attacks

2013-12-19
Stress reaction gene linked to death, heart attacks DURHAM, N.C. – A genetic trait known to make some people especially sensitive to stress also appears to be responsible for a 38 percent increased risk of heart attack or death in patients with heart disease, ...

Markers of inflammation in the blood linked to aggressive behaviors

2013-12-19
Markers of inflammation in the blood linked to aggressive behaviors Finding suggests new treatments for intermittent explosive disorder, aka 'road rage' People with intermittent explosive disorder — a psychiatric illness characterized by impulsivity, ...

Newly identified immune receptor may activate B cells in autoimmunity

2013-12-19
Newly identified immune receptor may activate B cells in autoimmunity BIRMINGHAM, Ala. – A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study ...

Heart disease linked with dementia in older postmenopausal women

2013-12-19
Heart disease linked with dementia in older postmenopausal women American Heart Association Rapid Access Journal Report Heart disease may put older postmenopausal women at higher risk for decreased brain function such as dementia, according to new ...

Modest weight loss may reduce heart disease, diabetes risks in middle-aged women

2013-12-19
Modest weight loss may reduce heart disease, diabetes risks in middle-aged women American Heart Association Rapid Access Journal Report Modest weight loss over 2 years in overweight or obese, middle-aged women may reduce risk factors for heart disease and diabetes, ...

Immune avoidance mechanism could lead to treatments for deadly mosquito-borne viruses

2013-12-19
Immune avoidance mechanism could lead to treatments for deadly mosquito-borne viruses PITTSBURGH, Dec. 18, 2013 – A mosquito-borne virus that kills about half of the people it infects uses a never-before-documented mechanism to ...

Neanderthal genome shows early human interbreeding, inbreeding

2013-12-19
Neanderthal genome shows early human interbreeding, inbreeding First high-quality genome sequence allows comparison with human, Denisovan DNA The most complete sequence to date of the Neanderthal genome, using DNA extracted from a woman's toe bone ...

Telecommunications data show civic dividing lines in major countries

2013-12-19
Telecommunications data show civic dividing lines in major countries New study uses network data to show communication patterns and divisions in many major nations Many residents of Britain, Italy, and Belgium imagine there to be a kind of north-south divide ...

LAST 30 PRESS RELEASES:

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

[Press-News.org] No link between HIV-prevention pill Truvada and increased sexual risk behavior
Biological markers confirm behavioral data; underscore drug's effectiveness